Contents

Search

revumenib

Indications: - relapsed or refractory KMT2A-rearranged or NPM1-mutant acute leukemia Mechanism of action: - menin inhibitor

General

small inhibitory antineoplastic agent (ib drug)

References

  1. Brooks M Novel Drug Leads to 'Impressive' Responses in Advanced Leukemia. Medscape. March 20, 2023 https://www.medscape.com/viewarticle/989871